Physician

Raafay Sophie, MD

According to 2025 Medicare claims, Raafay Sophie, MD (NPI: 1285044107) practices ophthalmology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is VITREORETINAL SPECIALISTS PLC (NPI: 1144582438; TIN: 455263774) and primary practice location at 48439-8301. Sophie is affiliated with the Genesys PHO, L.L.C. (ACO ID: A2597), participating under the MSSP model.

Sophie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 555 traditional Medicare patients, billed 24,220 HCPCS/CPT codes, and received $1,197,915 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 710 prescription claims across 215 beneficiaries totaling $27,584 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 34 records totaling $66,519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $13,988 to $1,197,915. Similarly, Part D prescription costs have risen steadily, from $5,145 to $27,584. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$599K$1.2M2018 Medicare payment: $13,988 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $28,982 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $156,925 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $513,453 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $770,726 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $916,465 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,197,915 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018120206$13,988
2019238438$28,982
2020239957$156,925
20213993,050$513,453
20225045,067$770,726
202350913,590$916,465
202455524,220$1,197,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$28K2015 Drug cost: $5,145 (USD; Tot_Drug_Cst)2016 Drug cost: $2,869 (USD; Tot_Drug_Cst)2017 Drug cost: $3,741 (USD; Tot_Drug_Cst)2018 Drug cost: $11,466 (USD; Tot_Drug_Cst)2019 Drug cost: $14,053 (USD; Tot_Drug_Cst)2020 Drug cost: $8,561 (USD; Tot_Drug_Cst)2021 Drug cost: $17,671 (USD; Tot_Drug_Cst)2022 Drug cost: $27,199 (USD; Tot_Drug_Cst)2023 Drug cost: $24,836 (USD; Tot_Drug_Cst)2024 Drug cost: $27,584 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201515102$5,145
2016N/R21$2,869
20173680$3,741
2018107313$11,466
2019147345$14,053
2020114251$8,561
2021151381$17,671
2022197613$27,199
2023193576$24,836
2024215710$27,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye213793$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more187299$90
92014Established patient complete exam of visual system268365$79
92134Imaging of retina4761,208$28
92202Extended exam of the back part of the eye with optic nerve drawing178182$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1888,260$9,357
Ketorolac TromethamineKetorolac Tromethamine1544,838$5,527
DifluprednateDifluprednate401,294$3,594
Bromfenac SodiumBromfenac Sodium12365$2,407
Brimonidine TartrateBrimonidine Tartrate996,250$1,682

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$2,135Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.14$64,384Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Raafay Sophie, MD?

Tedicare shows public-source Medicare data for Raafay Sophie, MD (NPI 1285044107), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raafay Sophie, MD have ACO affiliation data?

Raafay Sophie, MD is shown with ACO affiliation data for Genesys PHO, L.L.C. (MSSP, ACO ID A2597).

What billing organization is linked to Raafay Sophie, MD?

Raafay Sophie, MD is linked to VITREORETINAL SPECIALISTS PLC (billing NPI 1144582438) in the available physician profile data.

Does Raafay Sophie, MD have Open Payments data?

Raafay Sophie, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.